Application of ursodeoxycholic acid in hepatobiliary scintigraphy for neonatal hyperbilirubinemia: Comparison with phenobarbital

Iranian Journal of Nuclear Medicine

Volumn 17, Issue 2, 2009, Pages 20-25

  Khorasani, Enayatollah Nemat ^a   Mansouri, Fariba ^a  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

99mTc BRIDA; Hepatobiliary scintigraphy; Infantile jaundice; Neonatal hyperbilirubinemia; Ursodeoxycholic acid

Indexed keywords

DIGLYCINE TECHNETIUM TC 99M; PHENOBARBITAL; URSODEOXYCHOLIC ACID;

ARTICLE; BILE DUCT ATRESIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEEDING DISORDER; HUMAN; INFANT; IRRITABILITY; LETHARGY; LIVER SCINTISCANNING; MUSCLE HYPOTONIA; NEWBORN JAUNDICE;

EID: 77950466173     PISSN: 16812824     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Balistreri WF. Neonatal cholestasis. J Pediatr 1985;106:171-184.
2. Miyano T, Fujimoto T, Ohya T, Shimomura H. Current concept of the treatment of biliary atresia. World J Surg 1993;17:332-336.
3. Roach JP,Bruny JL. Advances in the understanding and treatment of biliary atresia. Curr Opin Pediatr 2008;20:315-319.
4. Mieli-Vergani G, Howard ER, Portman B, Mowat AP. Late referral for biliary atresia: missed opportunities for effective surgery. Lancet 1989;1:421-423.
5. Burton EM, Babcock DS, Heubi JE, Gelfand MJ. Neonatal jaundice: clinical and ultrasonographic findings. South Med J 1990;83:294-302.
6. 99mTc-IDA scintigraphy in the evaluation of neonatal jaundice. Semin Nucl Med 1981;11:194-204.
7. Gilmour SM, Hershkop M, Reifen R, Gilday D, Roberts EA. Outcome of hepatobiliary scanning in neonatal hepatitis syndrome. J Nucl Med 1997;38:1279-1282.
8. Gupta DK, Charles AR, Srinivas M, Dave S, Bal CS. Betamethasone in plus phenobarbitone prior to hepatobiliary scintigraphy increases diagnostic accuracy in infants with jaundice. Indian J Pediatr 2001;68:1039-1041.
9. Poddar U, Bhattacharya A, Thapa BR, Mittal BR, Singh K. Ursodeoxycholic acid-augmented hepatobiliary scintigraphy in the evaluation of neonatal jaundice. J Nucl Med 2004;45:1488-1492.
10. 99mTc sestamibi imaging - can it be a useful substitute for hepatobiliary scintigraphy in infantile jaundice? Nuklearmedizin 2009;48:100-103.
11. Jeong HJ,Kim CG. Pretreatment with ursodeoxycholic acid (UDCA) as a novel pharmacological intervention in hepatobiliary scintigraphy. Yonsei Med J 2005;46:394-398.
12. Colombo C, Crosignani A, Battezzati PM, Castellani MR, Comi S, Melzi ML et al. Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease. J Hepatol 1999;31:672-677.
13. Colombo C, Castellani MR, Balistreri WF, Seregni E, Assaisso ML, Giunta A. Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease. Hepatology 1992;15:677-684.
14. 99mTc-N-pyridoxyl-5-methyltryptophan in chronic liver diseases]. Nippon Shokakibyo Gakkai Zasshi 1988;85:2389-2395.
15. Sadeghi R. Evidence based medicine in nuclear medicine practice. Part I: Introduction, Asking answerable questions and searching for the best evidence. Iran J Nucl Med 2009;17(1):41-48.
16. Sadeghi R. Evidence based medicine in nuclear medicine practice. Part II: Appraising and applying the evidence. Iran J Nucl Med 2009; 17(1):49-56.
17. Rodeck B, Becker AC, Gratz KF, Petersen C. Early predictors of success of Kasai operation in children with biliary atresia. Eur J Pediatr Surg 2007;17:308-312.
18. 99m diisopropyl iminodiacetic acid hepatobiliary scintigraphy in differentiating biliary atresia from neonatal hepatitis syndrome. J Med Assoc Thai 2003;86 Suppl 2:S189-194.
19. Ullrich D, Rating D, Schroter W, Hanefeld F, Bircher J. Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation. Lancet 1987;2:1324.
20. Sarva RP, Fromm H, Farivar S, Sembrat RF, Mendelow H, Shinozuka H et al. Comparison of the effects between ursodeoxycholic and chenodeoxycholic acids on liver function and structure and bile acid composition in the Rhesus Monkey. Gastroenterology 1980;79:629-636.
21. Willot S, Uhlen S, Michaud L, Briand G, Bonnevalle M, Sfeir R et al. Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia. Pediatrics 2008;122:e1236-1241.
22. Tarao K, Fujiyama S, Ohkawa S, Miyakawa K, Tamai S, Hirokawa S et al. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis. Cancer Epidemiol Biomarkers Prev 2005;14:164-169.
23. Johnson K, Alton HM, Chapman S. Evaluation of mebrofenin hepatoscintigraphy in neonatal-onset jaundice. Pediatr Radiol 1998;28:937-941.